Rablip-D

Rablip-D is a combination formulation of Rabeprazole Sodium, a proton pump inhibitor, and Domperidone, a prokinetic and antiemetic agent. Rabeprazole works by suppressing gastric acid secretion, while Domperidone enhances gastrointestinal motility and helps prevent nausea and vomiting.

This dual action makes Rablip-D effective in the management of gastroesophageal reflux disease (GERD), acid reflux, functional dyspepsia, gastritis, and other acid-related disorders associated with delayed gastric emptying. It helps relieve symptoms such as heartburn, bloating, epigastric discomfort, nausea, and vomiting.

Rablip-D is commonly prescribed to provide both acid control and improved gastric motility, ensuring better symptom relief and patient comfort. It should be used as directed by a healthcare professional.